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Abstract
Background: Well-organized screening and treatment programmes are effective to prevent Invasive Cervical
Cancer (ICC) in LMICs. To achieve this, the World Health Organization (WHO) recommends the involvement of
existing health personnel in casu doctors, nurses, midwives in ICC prevention. A necessary precondition is that
health personnel have appropriate knowledge about ICC. Therefore, to inform policy makers and training
institutions in Burundi, we documented the knowledge and practices of general practitioners (GPs) at district
hospital level towards ICC control.
Methods: A descriptive cross-sectional survey was conducted from February to April, 2015 among all GPs working
in government district hospitals. A structured questionnaire and a scoring system were used to assess knowledge
and practices of GPs.
Results: The participation rate was 58.2%. Majority of GPs (76.3%) had appropriate knowledge (score > 70%) on
cervical cancer disease; but some risk factors were less well known as smoking and the 2 most important
oncogenic HPV. Only 8.4% of the participants had appropriate knowledge on ICC prevention: 55% of the
participants were aware that HPV vaccination exists and 48.1% knew cryotherapy as a treatment method for CIN.
Further, 15.3% was aware of VIA as a screening method. The majority of the participants (87%) never or rarely
propose screening tests to their clients. Only 2 participants (1.5%) have already performed VIA/VILI. Wrong thoughts
were also reported: 39.7% thought that CIN could be treated with radiotherapy; 3.1% thought that X-ray is a
screening method.
Conclusion: In this comprehensive assessment, we observed that Burundian GPs have a very low knowledge level
about ICC prevention, screening and treatment. Suboptimal practices and wrong thoughts related to ICC screening
and treatments have also been documented. We therefore recommend an adequate pre- and in-service training of
GPs and most probably nurses on ICC control before setting up any public health intervention on ICC control.
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Background
Worldwide, invasive cervical cancer (ICC) is the fourth
most common female cancer after breast cancer, colo-
rectal cancer and lung cancer [1]. In 2012, the number
of new cases was estimated at 528000, corresponding to
an age-standardised incidence rate of 14 per 100,000
women. The number of deaths attributed to ICC was es-
timated at 266000, corresponding to an age-standardised
mortality rate of 6.8/100000 women [1]. Huge disparities
in ICC control exist between High and Low & Middle
Income Countries (LMICs), mainly due to the limited
human capacity and infrastructure and other competing
priorities in LMICs [2–4]. Around 85% of new ICC cases
and 88% of ICC related deaths occurred in LMICs
mainly in sub-Saharan Africa and South-East Asia [1, 2,
5]. In sub-Saharan Africa, in particular in Eastern Africa,
ICC is the most common female cancer with an age-
standardised incidence and mortality rates of 42.7 and
27.6 per 100,000 women respectively [1]. Burundi is not
exempted with an annually estimated incidence of 1429
ICC cases and 1080 deaths, corresponding to an annu-
ally age-standardised incidence and mortality rates of
49.3 and 39.3 per 100,000 women respectively [1, 6].
Currently, despite the high burden of ICC, there is no
national organized cervical cancer screening strategy in
Burundi. Pap smear can only be done at the teaching
hospital in Bujumbura, Roi Khaled, when gynaecologists
propose it to their clients and the latter are able to af-
ford this service. As a result, very few women are
screened and few have heard about cervical cancer pre-
vention. The only functional pathology laboratory in the
country is hampered by frequent stock out of reagents,
very old equipment and insufficient personnel as there
are only 2 pathologists and 3 cyto-technicians with only
bench training [7].
Therefore, the Burundian health system needs to im-
plement a cervical cancer programme that provides af-
fordable, accessible and acceptable services to ensure
adequate coverage to the target population. These ser-
vices should be provided by skilled and competent
health workers. Research and experience have proven
that well-organized screening and treatment pro-
grammes are highly effective in ICC prevention in
LMICs [6, 8, 9]. In order to achieve this, the World
Health Organization (WHO) recommends the involve-
ment of existing health personnel in casu doctors,
nurses, midwives and all available health agents in
ICC prevention [10]. To comply with this recommen-
dation, the first step is to make sure that health
personnel have appropriate knowledge about cervical
cancer control so that they are able to play a sustain-
able role in ICC control.
The Ministry of Health (MOH) in Burundi, through
its non-communicable diseases control programme
“PNILMCNT” (Programme National Intégré de Lutte
contre les Maladies Chroniques non Transmissibles), has
recently developed a cancer national strategic plan
2016–2020, including ICC control. This strategic plan
calls for implementation of an ICC screening strategy,
typically using Visual Inspection with 5% Acetic acid
(VIA)/Visual Inspection with Lugol’s Iodine (VILI) and
cytology where feasible, followed by treatment of pre-
cancerous lesions with cryotherapy. However, there is a
lack of information about the knowledge and practices
of the existing health personnel towards ICC prevention.
The Burundian health system mostly relies on nurses
and General Practitioners (GPs). These GPs are assumed
to be the most knowledgeable staff working at District
hospitals. They supervise nursing staffs assisting them in
all their activities. To our knowledge, there are no avail-
able studies assessing the knowledge and practices of
GPs about cervical cancer prevention in Burundi.
The aim of this study was to document the knowledge
and practices of GPs at district hospital level towards
ICC control to inform policy makers and training insti-
tutions on their actual knowledge and practices.
Methods
Study design
A cross-sectional survey was conducted from February
to April, 2015 among all GPs working in the government
District hospitals in Burundi.
Setting, sampling and recruitment
The Burundi health system is composed of 48 govern-
ment district hospitals. The health staffs at these health
districts are composed of GPs and nurses, except in very
few hospitals where there are also midwives. During the
year 2015, the 48 government district hospitals had a
total of 225 GPs. Each district hospital was visited by an
investigator during 3 consecutive working days. We
aimed to reach all GPs working in district hospitals and
all GPs present on site the day of the visit were
approached individually and invited to participate in the
study. The investigator explained the purpose of the
study and after giving their verbal consent, participants
were given a questionnaire to fill in. A total of 131 GPs
were found at their working place and all accepted to
participate in our study. The remaining 94 GPs were on
a work assignment elsewhere or on leave and could not
be found to be part of the investigation during the time-
frame of our survey. Information related to age, sex and
professional experience for GPs not present during the
3 days of the visit was also obtained through the man-
agement team of the hospital (each personnel has an
individual folder kept by the Directorate). Whenever
possible, each GP not present were called on his mobile
phone to confirm this information.
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Data collection
We found, through literature review, a survey question-
naire and a scoring system assessing knowledge, atti-
tudes and practices of health professionals regarding
ICC in Côte d’Ivoire [4]. An expert panel composed out
of an epidemiologist, gynaecologist, public health experts
and scientists reviewed and adapted some questions
from these tools to allow us to capture knowledge and
practices of GPs in our context. The adapted question-
naire has been pre-tested on 15 professionals (06 gynae-
cologists, 04 residents in Gynaecology Obstetrics and 5
GPs) working at the tertiary hospital, Roi Khaled, to
check how understandable were the questions and esti-
mate the time required for its full filling in. A Cronbach
alpha coefficient, to check for the internal consistency of
this tool was 0.63. This tool was found to be satisfactory
and was used to collect data.
The questionnaire, consisting of closed (multiple
choice) questions, was designed to collect data on
demographic characteristics of GPs, their knowledge
related to ICC and its prevention options, and their
daily practices about proposing cervical cancer
screening to their clients.
The knowledge was evaluated using two scores. The
first score assessed knowledge of epidemiology and risk
factors for cervical cancer. The second score evaluated
knowledge of cervical cancer prevention methods,
screening and vaccination. The first score was composed
of 12 questions and the second score was composed of
17 questions, each worth one point. Regarding GPs
practices, participants were asked if they propose screen-
ing for cervical cancer to their eligible clients. They were
given these choices: never, rarely (less than 20% of their
eligible clients), often (20%–60% of the eligible clients)
and always. An open question was added to collect
reasons for never/rarely proposing a screening test.
After the completion of the questionnaires, data were
entered into excel sheets by two different desk clerks.
The two databases were compared in order to verify
registration errors.
Statistical analysis
We created two variables: “Knowledge of cervical cancer
disease” corresponding to the first score and “Knowledge
of cervical cancer prevention” was corresponding to the
second one. The first score was composed of 3 questions
related to epidemiology and 9 questions on risk factors.
The second score was built using 6 questions on pre-
ventive methods, 5 questions on screening techniques
and 6 questions related to HPV vaccination. Each time a
correct answer was given; 1 point was added to the
score. For some questions which had two correct an-
swers, if one correct answer was given, 0.5 point was
added to the score and if no correct answer was given,
the corresponding mark was 0 point (Table 1). The max-
imum value for the first score was 12 points, equivalent
to 100% and 17 points for the second score, also
equivalent to 100%. Each score was dichotomized into
Table 1 Construction of scores for the assessment of knowledge on cervical cancer among GPs, 2015
Items studied Topics Number of questions Theme of questions Topic value Total score Scale of analysis
Score of knowledge on
cervical cancer disease
Epidemiology 3 Incidence Min = 0 Max = 3 12 0–100%
Mortality
Age
Risk factors 9 HPV Min = 0 Max = 9
Sexuality
Tabac
Multiparity
Score of knowledge on
cervical cancer prevention
Prevention methods 6 Vaccine Min = 0 Max = 6 17 0–100%
Screening
Treatment of low grade lesions
Screening 5 Type of test Min = 0 Max = 5
VIA
HPV test
Age
Vaccination 6 Availability Min = 0 Max = 6
Target
Doses
names
schedule of doses
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“Appropriate” when the score was >70% and “Inappro-
priate” when the score was ≤70%.
Chi2 test was used to compare proportions of female
participants and non-participants. Fisher’s exact test was
used (in case of small numbers) to compare proportions
of GPs with appropriate knowledge (both on ICC disease
and prevention) among:
1) GPs who never/rarely propose screening test and
GPs who often/always propose screening.
2) GPs with professional experience of less than or
equal to 1 year and GPs with professional experience
of more than 1 year.
Kruskal-Wallis test was used to compare the median
age (both years of life and years of professional experi-
ence) of participants and non-participants.
A p-value <0.05 was considered as statistically signifi-
cant. The analysis was performed using stata 13 software.
Ethical aspects
The study protocol was approved by the Burundian National
Ethics Committee and we also had an oral agreement of the
District Medical Officer (DMO) and/or director of the hospital
in each district hospital in which the survey was conducted.
Participation in the study was entirely voluntary and
participants provided a verbal consent after having been ex-
plained the objectives of the study and ensured confidentiality.
Results
Demographic characteristics
Out of 48 public hospitals in Burundi, 45 district
hospitals were visited; a 3 hospitals had security
issues at the time of the survey. A total of 131 GPs
(58.2%) of the 225 were present on their duty the day
of the visit and all of them (100%) accepted to
participate in the study. The median age of the par-
ticipants was 33 years, (interquartile range [IQR]:32–
35). Among the participants, 13 (10%) were female.
The median professional experience duration of the
participants was 2 years (IQR: 1–3).
Knowledge of cervical cancer
Overall, 100 participants (76.3%) had appropriate know-
ledge (score > 70%) on cervical cancer disease. The
topics ‘Risk factors’ and ‘Epidemiology’ were best known
by the participants – compared with topics related to
preventive practices - whereby 68.7% and 64.1% respect-
ively had appropriate knowledge.
More than 90% of the participants knew the 2 most
frequent cancers in Burundian women. Similarly, more
than 90% knew that early sexual intercourse debut, many
sexual partners and Human Papillomavirus (HPV)
infection are risk factors for ICC; 89% knew that HPV is
isolated in most cervical cancer cases.
On the other hand, only 68.7% of the participants
knew the most affected age group; 50.4% knew that high
parity is a risk factor for ICC, and only 49.6% knew that
smoking is a risk factor for cervical cancer. Only 19 par-
ticipants (14.5%) knew the 2 most important oncogenic
HPVs (Table 2).
Knowledge of cervical cancer prevention
Overall, only 11 participants (8.7% of respondents) had
appropriate knowledge (score > 70%) on cervical cancer
prevention. The items related to “Vaccination” and
“screening” were less known by our participants whereby
only 1 participant (0.8%) and 18 participants (13.7%) re-
spectively had appropriate knowledge. Regarding preven-
tion in general, 55% of the participants was aware that
HPV vaccination is a preventive method of ICC and only
48.1% knew that cryotherapy is a treatment method for
cervical intraepithelial neoplasia. In terms of screening,
only 15.3% was aware that Visual Inspection with Acetic
acid (VIA) is a screening method, compared with 82%
knowing that HPV screening tests exist. With regard to
vaccination, only 10.7% knew the target age group
chosen by the Burundi ministry of Health for HPV vac-
cine (i.e. 9-13 years); 4.6% knew the names of commer-
cially available vaccines; 3.1% knew the required doses
for HPV vaccination completion and only one partici-
pant knew the timeline of HPV vaccination (Table 2).
Practice of GPs
Our results showed that 87% of the participants never or
rarely (42.7% and 44.3% respectively) propose screening to
their clients. None of the participants reported to always
propose screening test to his/her clients. Only 13% reported
to often propose the screening test to their clients (Table 3).
Only 36.6% of the participants have heard about VIA/
VILI and among them, only 2 (1.5%) have already per-
formed VIA/VILI.
The most reported reasons for never or rarely propos-
ing screening test (Table 2, N = 114)) were:
1) Screening centre not available at (or around) their
working places (75.4% of respondents),
2) Ignorance of GPs (49.1% of respondents)
(meaning GPs not trained on cervical cancer
screening techniques, GPs forget to ask screening
because they don’t have the habit of doing so,
GPs think that the prevalence of CC is very low
and thus not worth to worry about it, GPs are
not sensitised about cervical cancer, GPs think
that the management of CIN is not feasible in
Burundi);
3) Financial barriers for their clients (28.1%);
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4) Women don’t come for screening (14%)(they come
at a late stage, they hide their early sexual debut,
women not sensitised on the interest of doing
CC screening)
5) GPs are overloaded (7%)
6) and the late response of the pathology lab (0.9%).
Among our participants, we noticed high proportions
of wrong answers: 39.7% of the participants thought that
CIN could be treated with radiotherapy and 26.7% sug-
gested treating CIN with hysterectomy; 19.1% thought
that vaginal ultrasound is a screening method and 3.1%
thought that X-ray of the pelvis is a screening method
for cervical cancer.
We sought to know if there would be an association be-
tween knowledge of ICC (disease or prevention) and practice
(=proposing screening for cervical cancer), and found no as-
sociation (p= 0.18; p= 0.14 respectively) suggesting that
those who have appropriate knowledge (score > 70%) about
ICC disease or prevention are not more proposing screening
to their clients than those who have less knowledge.
However, we found an association between
professional experience and knowledge of cervical
cancer disease. Those having less experience have better
knowledge on cervical cancer disease than those with
more experience (>1 year) (p = 0.038). We did not
observe any significant association between experience
and knowledge of ICC prevention (Table 4).
Table 2 Knowledge of GPs about cervical cancer disease and prevention, Burundi 2015
Items studied Topics Question theme Total score
N = 131 (%)
Score (>70%)
by topic
Score of knowledge
(>70%)
Knowledge on cervical
cancer disease
Epidemiology Knew the 2 Most frequent cancer in women ǂ 118(90.1) 84 (64.1%) 100 (76.3%)
Knew the 2 Most deadly cancer in womenǂǂ 99 (75.6)
Knew the most affected age group(40-64 years) 90 (68.7)
Risk factors Knew that HPV is a STI 115 (87.8) 90 (68.7%)
Knew early sexual debut(<17 years) is a risk factor(RF) 129 (98.5)
Knew that many sexual partners is a RF 129 (98.5)
Knew that HPV infection is a risk factor 127 (96.5)
Knew that multiparity is a risk factor 66 (50.4)
Knew that smoking is a risk factor 65 (49.6)
Knew that HPV is present in most CC cases 117 (89.3)
Knew that HPV can cause condyloma 113 (86.3)
Knew the 2 important oncogenic HPV(16–18 types) 19 (14.5)
Knowledge on cervical
cancer prevention
Prevention methods Knew that cervical cancer is preventable 127 (97.2) 64 (50.4%) 11 (8.4%)
Aware that vaccine is a preventive method 70 (55.1)*
Aware that screening is a preventive method 117 (92.1)*
Aware that treatment of CIN is a preventive method 113 (89)*
Knew that LEEP is a treatment method for CIN 85 (64.9)
Knew cryotherapy is a treatment method for CIN 63 (48.1)
Screening Aware pap smear is a screening method 126 (96.2) 18 (13.7%)
Aware VIA is a screening method 20 (15.3)
Aware VILI is a screening method 41 (31.3)
Aware HPV test is a screening method 108 (82.4)
Knew age to start cervical cancer screening 20 (15.3)
Vaccination Aware of existence of HPV vaccine 86 (65.6) 1 (0.8%)
Knew target group for HPV vaccine 90 (68.7)
Knew target group chosen by Burundi 14 (10.7)
Knew names of commercially available vaccines 6 (4.6)
Knew required doses to complete HPV vaccination 4 (3.1)
Knew timeline of HPV vaccination 1 (0.8)
*N = 127, ǂ: Cervical cancer and breast cancer; ǂǂ: Cervical cancer and breast cancer
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Discussion
This study is one of the few presenting the knowledge
and practices of general practitioners towards cervical
cancer disease and its prevention and the first one in
Burundi. These physicians working at district hospital
level are involved in women’s primary care and are
well trusted by their clients. We undertook this study
in order to inform policy makers and training institu-
tions about their level of knowledge and practices on
cervical cancer disease and prevention. More than
half of our participants had good knowledge about
risk factors and epidemiology of cervical cancer. On
the other hand, knowledge about screening techniques
and vaccination was very low (only 13.7% and 0.8%
respectively had appropriate knowledge i.e. a score >
70%). Our study revealed important gaps in the cer-
vical cancer prevention knowledge whereby only 8%
of the participants had appropriate knowledge about
prevention (score > 70%). Our findings are in line with
results from others studies on health professionals
pointing out inadequate knowledge about cervical
cancer prevention [11, 12]. This low knowledge on
CC prevention is probably due to the fact that inva-
sive cervical cancer has been neglected: there is no
national programme for screening or vaccination and
GPs are not sensitized on ICC prevention activities.
Much emphasis has been put on other diseases like
HIV/AIDS, tuberculosis and malaria for which differ-
ent control programmes exist and are funded by gov-
ernment and its partners; this is not the case for
cervical cancer. Low knowledge in cervical cancer
prevention has also been reported in studies done in
other settings [13–15]. In Tunisia, in a study done
among medical students at the end of their curricu-
lum, pointed out that more than 70% of the partici-
pants did not know when to start cervical cancer
screening and neither did they know the periodicity.
The study concluded that cervical cancer control
training was insufficient and should be improved and
restructured [16].
Indeed, the low knowledge level in our study points
out insufficient training at the faculties of Medicine
in Burundi. In fact, training programmes in cancer
control in general and cervical cancer in particular,
are poorly or not at all developed. Cervical cancer
control is briefly outlined in the module of
Gynaecology. The practical training in cervical cancer
control (screening and vaccination) is not available in
Burundi. Roi Khaled, the main University teaching
hospital in Burundi, does not have any cervical cancer
control unit. It is neither equipped with a cryotherapy
machine, LEEP machine, colposcopy machine nor
practices HPV vaccination. Moreover, the health
providers stationed in this department are not trained
Table 3 Practices of GPs and reasons for never/rarely proposing
screening, Burundi 2015
Variable n (%)
Propose screening test (N = 131)
Never 56 (42.7)
Rarely 58 (44.3)
Often 17 (13)
Always 0 (0)
Have heard about VIA/VILI (N = 131) 48 (36.6)
Have already performed VIA/VILI (N = 131) 2 (1.5)
Have heard about HPV screening (N = 131) 90 (68.7)
Reasons for never or rarely proposing screening (N = 114)
Screening center not available 86 (75.4)
Ignorance of GPs 56 (49.1)
Financial obstacles 32 (28.1)
women don’t come 16 (14)
GPs overloaded 8 (7)
Late response of the pathology laboratory 1 (0.9)
Thoughts of GPs about ICC prevention (N = 131)*
Think radiotherapy is a treatment of CIN 52 (39.7)
Think CIN can be treated with hysterectomy 35 (26.7)
Think vaginal echography is a screening method ICC 25 (19.1)
Think RX pelvis is a screening method for cervical cancer 4 (3.1)
*The respondents who gave these answers are wrong
Table 4 Association between knowledge and practice and professional experience
Variable Knowledge disease (n = 131) Knowledge prevention (n = 127)
Score > 70% Score≤ 70% p-value Score > 70% Score≤ 70% p-value
Propose screening
Never/rarely 85 (74.6) 29 (25.4) 0.18* 8 (7.2) 103 (92.8) 0.14*
Often/always 15 (88.2) 2 (11.8) 3 (18.8) 13 (81.2)
Experience
≤ 1 year 42 (85.7) 7 (14.3) 0.038* 4 (8.7) 42 (91.3) 0.61*
> 1 year 58 (70.7) 24 (29.3) 7 (8.7) 74 (91.4)
*p Fisher exact test
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in screening for cervical cancer, HPV vaccination and
colposcopy.
To our knowledge, the same situation prevails in all
public and private hospitals, including at tertiary level.
Our study showed a significant association between
knowledge of cervical cancer disease and professional
experience whereby the proportion of GPs with less
experience having appropriate knowledge on ICC disease
(score > 70%) was significantly higher than the more ex-
perienced GPs. This would suggest that GPs with more
professional experience know less than the younger GPs.
We hypothesised that this could be explained by the fact
that the questions about epidemiology and risk factors
are theoretical knowledge and the younger GPs are more
likely to know it because they recently graduated from
faculties. Moreover, there is no organised in-service
training for GPs on this topic. Importantly, the study re-
vealed no association between appropriate knowledge of
cervical cancer (disease and prevention) and practice
(=proposing screening). This result suggests that GPs
with appropriate knowledge about cervical cancer do
not propose more screening tests to their clients than
those with insufficient knowledge. The reasons for that
situation are likely the absence of screening centre at/or
around their working places and other reasons as it has
been reported (Table 3).
The present study provides a preliminary identification
of gaps in physician’s knowledge about cervical cancer
prevention and its epidemiology. Our ultimate hope is
that it will allow tailoring a more targeted educational
programme. The key areas of focus should include the
HPV vaccination, cervical cancer screening techniques
and prevention methods.
The study shows that majority of the participants
never or rarely propose to their clients a screening test
for cervical cancer and as expected, the reported reasons
for that are screening centre not available at/or near
their working places or even for some in the whole
country (75%); 50% of GPs acknowledged their ignor-
ance for cervical cancer screening.
For GPs who dare to ask for a pap smear, they are
disappointed by the late response from the pathology
laboratory. In fact, this is also another big challenge in
our context where the pathology lab suffers from many
malfunctioning (insufficient qualified staff, frequent
stock outs of reagents, inadequate equipment, etc.). This
is in line with results from other low resource settings
pointing out the ineffectiveness of cytology-based
screening programs in resource constraints settings [11,
14]. This situation has led to the development of other
alternative screening modalities for LMICs such as VIA
and rapid, low-cost HPV DNA testing that do not re-
quire follow-up visits and have been successfully used in
low and middle resource settings [17, 18]. However, our
results revealed that the vast majority of GPs (64%) had
never heard of the VIA/VILI screening methods; and im-
portantly, only 2 participants had already performed
VIA/VILI. This situation calls for attention because
these screening modalities are likely the most feasible
in our context. Therefore, training and education
about these alternative approaches is critical and
should be made a training priority for health care
providers involved in women’s primary care as some
steps are being taken to scale up VIA cervical cancer
screening in Burundi.
Surprisingly, the study revealed a high proportion of
wrong answers of our participants about cervical intrae-
pithelial neoplasia treatment and screening techniques
(Table 3). In line with what have been described above,
this also denotes a lack of training.
Study limitations
The participation rate was only 58.2% of the total GPs
working at district level (three district hospitals were not
visited due to security issues and some general practitioners
at district hospitals visited were not at their working place).
We think this limitation does not have important implica-
tions as the participants and non participants to our study
had roughly the same characteristics (Table 5).
A second limitation could be related to the cronbach
alpha coefficient of our tool of 0.63 which might be con-
sidered as low by some authors. However, other authors
support the hypothesis that Cronbach’s alpha values
higher than 0.60 could be acceptable [19].
Table 5 Characteristics of participants and non participants
Characteristic Participants (N = 131) Non-participants (N = 94) P-value
Age, years
Median (IQR) 33 (32–35) 34 (32–37) 0.04*
Sex
Female (%) 13 (10%) 15 (16%) 0.18**
Professional experience, years
Median (IQR) 2 (1–3) 2.5 (1–5) 0.19*
*=Kruskal-Wallis test;
**= Chi2test
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Conclusion
A very low knowledge level about cervical cancer preven-
tion, screening and treatment exists among Burundian gen-
eral practitioners. GPs practices are also suboptimal. A high
proportion of wrong thoughts related to CC screening and
treatments have also been documented. If knowledge
among GPs is so low, knowledge among nurses should also
be investigated since they can greatly assist in cervical can-
cer control. We therefore recommend pre- and in-service
training of GPs, among others, before setting up any public
health intervention on cervical cancer control. If this rec-
ommendation is met and health services strengthened with
investment in adequate infrastructure, cervical cancer con-
trol programme can then be successfully implemented.
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